Literature DB >> 6272058

Characterization of the electrogenic sodium channel from rat brain membranes using neurotoxin-dependent 22Na uptake.

J C Matthews, J E Warnick, E X Albuquerque, M E Eldefrawi.   

Abstract

The sodium channel was studied in osmotically-sensitive membrane preparations from rat brain and in innervated and chronically denervated rat soleus and extensor digitorum longus muscles. These experiments were undertaken in order to define a set of parameters for sodium channel function at the subcellular level to be used as a measure of retention of channel integrity upon subsequent isolation of the channel. Various neurotoxins and drugs were employed to control the permeability of the brain membranes to 22Na and the sodium-conductance properties of the muscles. Batrachotoxin (ED50 = 0.2 micrometer), veratridine (ED50 = 1 micrometer), or grayanotoxin I (ED50 = 30 micrometers) stimulated 22Na uptake in brain membranes is inhibited in an apparently uncompetitive manner by the sodium channel blocking agents tetrodotoxin and saxitoxin in a simple competitive manner by Ca2+ and in a partial or allosteric competitive manner by lidocaine and procaine. This 22Na uptake assay, which can be equated to a measure of equilibrium toxin binding, shows dependence on the concentration of the membranes and is sensitive to pH, temperature, ionic strength, and the ionic composition of the media. Parallel biophysical studies on sodium channels in rat muscle show that the properties of the sodium channel are similarly affected by these agents.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272058     DOI: 10.3109/09687688109065424

Source DB:  PubMed          Journal:  Membr Biochem        ISSN: 0149-046X


  2 in total

1.  Effect of tetracaine on veratrine-mediated influx of sodium into rat brain synaptosomes.

Authors:  S L Aksentsev; A A Rakovich; I M Okoon; S V Konev; S N Orlov; G M Kravtsov
Journal:  Pflugers Arch       Date:  1983-04       Impact factor: 3.657

2.  Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.

Authors:  G T Bolger; P Skolnick
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.